MedTrace Logo

Narrow-band Imaging, Autofluorescence Imaging and Gastroesophageal Reflux Disease

NCT01504971 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2015-09-02

Study results available
· View outcomes & findings →

Summary

Aim of this study is to compare the efficacy of narrow band imaging (NBI) and autofluorescence imaging (AFI) to distinguish subtle mucosal change related to acid reflux that is not visible in standard white light imaging (WLI) endoscopy, and help indicating the diagnosis of gastroesophageal reflux disease (GERD).

Conditions

  • Gastroesophageal Reflux Disease

Interventions

OTHER

symptom questionaire

GerdQ questionaire

PROCEDURE

pH monitoring

24-hour pH monitoring

PROCEDURE

Tri-modal imaging endoscopy

To investigate WLI,NBI and AFI

DRUG

rabeprazole

10mg, bid, p.o.

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Shuzhang Li, MD · Chinese PLA General Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-06-30
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01504971 on ClinicalTrials.gov